Trial Outcomes & Findings for TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD (NCT NCT06271733)

Last Updated: 2026-02-20

Results Overview

Self-report measure of PTSD symptom severity. Scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity.

Recruitment status

COMPLETED

Study phase

Target enrollment

6 participants

Primary outcome timeframe

1 month-follow up

Results posted on

2026-02-20

Participant Flow

Participant milestones

Participant milestones
Measure	Transcranial Magnetic Stimulation (TMS) Veterans will receive 2 sessions of iTBS per day for 5 days during the second week of a 2-week IOP for PTSD at the Road Home Program.
Overall Study STARTED	6
Overall Study COMPLETED	6
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Transcranial Magnetic Stimulation (TMS) n=6 Participants Veterans will receive 2 sessions of iTBS per day for 5 days during the second week of a 2-week IOP for PTSD at the Road Home Program.
Age, Continuous	45 Years STANDARD_DEVIATION 6.6 • n=14 Participants
Sex: Female, Male Female	1 Participants n=14 Participants
Sex: Female, Male Male	5 Participants n=14 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=14 Participants
Race (NIH/OMB) Asian	0 Participants n=14 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=14 Participants
Race (NIH/OMB) Black or African American	1 Participants n=14 Participants
Race (NIH/OMB) White	4 Participants n=14 Participants
Race (NIH/OMB) More than one race	1 Participants n=14 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=14 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	2 Participants n=14 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	4 Participants n=14 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	0 Participants n=14 Participants
Region of Enrollment United States	6 Participants n=14 Participants
PTSD Checklist for DSM-5 (PCL-5)	54 Scores on a Scale STANDARD_DEVIATION 15.3 • n=14 Participants
Patient Health Questionnaire-9 (PHQ-9)	17.8 Scores on a Scale STANDARD_DEVIATION 5.2 • n=14 Participants

PRIMARY outcome

Timeframe: 1 month-follow up

Population: Out of six participants, five completed measures for the 1-month follow up.

Self-report measure of PTSD symptom severity. Scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity.

Outcome measures

Outcome measures
Measure	Transcranial Magnetic Stimulation (TMS) n=5 Participants Veterans will receive 2 sessions of iTBS per day for 5 days during the second week of a 2-week IOP for PTSD at the Road Home Program.
PTSD Checklist for DSM-5 (PCL-5)	30.8 Scores on a Scale Standard Deviation 26.9

SECONDARY outcome

Timeframe: 1 month follow up

Population: Five out of six participants completed the 1-month time point follow up.

Self-report measure of depression symptom severity. Scale ranges from 0 to 27, with higher scores indicating greater depression symptom severity.

Outcome measures

Outcome measures
Measure	Transcranial Magnetic Stimulation (TMS) n=5 Participants Veterans will receive 2 sessions of iTBS per day for 5 days during the second week of a 2-week IOP for PTSD at the Road Home Program.
Patient Health Questionnaire-9 (PHQ-9)	10.4 Scores on a Scale Standard Deviation 9.1

Adverse Events

Transcranial Magnetic Stimulation (TMS)

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Philip Held

Rush University Medical Center

Phone: 312-942-1423

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place